Latest News
- Min. Nadda Unveils ?13,000-Crore Bio-Pharma SHAKTI and Chemical Parks Push to Expand India’s Global Chemicals and Biologics Footprint
- Aurobindo Pharma Subsidiary Launches Generic Cancer Drug in US, Expands Oncology Portfolio in Global Generics Market
- KIMS Hospitals Introduces Adaptive Deep Brain Stimulation in India for Advanced Parkinson’s Treatment
Emcure launches Emcutix Biopharmaceuticals, a New Subsidiary Dedicated to Dermatology
Emcutix, led by seasoned industry expert G. Sathya Narayanan, will enhance Emcure’s presence in the skin health space, focusing on pioneering solutions that span both therapeutic and aesthetic dermatology.
- By Newsdesk
- New Delhi
- Oct 28, 2024
Emcure Pharmaceuticals Limited has launched Emcutix Biopharmaceuticals, a specialized subsidiary dedicated to dermatology. Emcutix, led by seasoned industry expert G. Sathya Narayanan, will enhance Emcure’s presence in the skin health space, focusing on pioneering solutions that span both therapeutic and aesthetic dermatology.
Mr. Narayanan, with over 30 years of experience, previously held the position of Managing Director at Galderma for the South Asia region. His extensive background in developing prominent dermatology brands positions him to lead Emcutix’s mission of addressing unmet dermatological needs in India. The new subsidiary will incorporate Emcure’s existing dermatology division, furthering its commitment to innovation with a robust team and plans for unique product offerings that meet diverse skin health requirements.
"Emcutix represents a unique opportunity with derma care solutions for healthcare professionals, patients and consumers by developing a differentiated dermatology portfolio. Building on Emcure’s legacy of innovation, I look forward to building a portfolio of products that will make a meaningful difference in skin health in India", he said.
Satish Mehta, CEO and Managing Director of Emcure Pharmaceuticals, highlighted the growing demand in India’s dermatology market, stating that Emcure is poised to meet these evolving needs through Emcutix’s targeted approach. Emcutix’s CEO, G. Sathya Narayanan, expressed enthusiasm about the venture’s potential to impact patient care by developing products that advance dermatological health across the country.